FdaApplication

NDA 050748

Back to search

Identifiers

Properties

PropertyValue
applicant_nameKING PHARMACEUTICALS INC
application_typeNDA
approval_date1999-09-21

Products (2)

ProductActive ingredientStrengthDosage form
SYNERCIDDALFOPRISTIN; QUINUPRISTIN350MG/VIAL;150MG/VIALINJECTABLE;INTRAVENOUS
SYNERCIDDALFOPRISTIN; QUINUPRISTIN420MG/VIAL;180MG/VIALINJECTABLE;INTRAVENOUS

2 products